DM
Showing 1 - 25 of >10,000
Birch Pollen Allergy Trial in Mississauga (DM-101PX, Placebo to Match DM-101PX)
Recruiting
- Birch Pollen Allergy
- DM-101PX
- Placebo to Match DM-101PX
-
Mississauga, Ontario, CanadaCliantha Research
Sep 18, 2023
Type 2 Diabetes Trial in Wauwatosa (DM-CCT, DM-UCT)
Recruiting
- Type 2 Diabetes
- DM-CCT
- DM-UCT
-
Wauwatosa, WisconsinMedical College of Wisconsin
Jan 30, 2023
Diabetes, Type 2 Trial in Milwaukee (MANAGe-DM - novel nurse case management, Monthly Educational Mailing)
Recruiting
- Diabetes Mellitus, Type 2
- MANAGe-DM - novel nurse case management
- Monthly Educational Mailing
-
Milwaukee, WisconsinCenter for Advancing Population Science, Medical College of Wisc
Sep 12, 2023
Type 2 Diabetes With Peripheral Angiopathy Trial in Karachi (Concurrent Training, Aerobic Training)
Enrolling by invitation
- Type 2 Diabetes With Peripheral Angiopathy
- Concurrent Training
- Aerobic Training
-
Karachi, Sindh, PakistanUroosa Amin
Sep 7, 2023
Type 2 Diabetes Trial (DM Social Needs, Usual Care)
Not yet recruiting
- Type 2 Diabetes
- DM Social Needs
- Usual Care
- (no location specified)
Jul 6, 2023
Paleolithic Diet in Control of Blood Level of Glucose in Type 2
Not yet recruiting
- Diabetic Patients
- Paleolithic diet effect on patients
-
Assiut, EgyptNagy Nageh Abdo
Mar 29, 2023
Myotonic Dystrophy 1 Trial (ARO-DM1 for Injection, Placebo)
Not yet recruiting
- Myotonic Dystrophy 1
- ARO-DM1 for Injection
- Placebo
- (no location specified)
Nov 14, 2023
Thyroid Function Among Pediatric Patients With DM
Not yet recruiting
- Thyroid Function in DM
- thyroid hormones
- (no location specified)
Feb 6, 2023
Advanced Cancer, Brain Metastases Trial in New Orleans (DM-CHOC-PEN)
Completed
- Advanced Cancer
- Brain Metastases
-
New Orleans, LouisianaTulane University Medical Center
Nov 3, 2022
Diabetes, Type 2 Trial (Magnetic Resonance Spectroscopy Imaging (MRSI))
Not yet recruiting
- Diabetes Mellitus, Type 2
- Magnetic Resonance Spectroscopy Imaging (MRSI)
- (no location specified)
Mar 8, 2023
CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy
Not yet recruiting
- Type 2 DM /Diabetic Nephropathy
- (no location specified)
Jan 28, 2023
Trastuzumab Emtansine as Therapy in Chinese HER2 Positive
Not yet recruiting
- Breast Cancer
- Trastuzumab emtansine
- (no location specified)
Jul 13, 2023
Advanced Cancer Trial in New Orleans, Detroit (4-Demethyl-4-cholesteryloxycarbonylpenclomedine)
Completed
- Advanced Cancer
-
New Orleans, Louisiana
- +2 more
Nov 3, 2022
Normoglycemia, T2DM (Type 2 Diabetes) Trial in New Delhi (Bread, Mango)
Completed
- Normoglycemia
- T2DM (Type 2 Diabetes Mellitus)
- Bread
- Mango
-
New Delhi, Delhi, IndiaFortis CDOC Hospital
Sep 20, 2023
Polymyositis, Dermatomyositis Trial in Gainesville (Umbilical Cord Lining Stem Cells)
Active, not recruiting
- Polymyositis
- Dermatomyositis
- Umbilical Cord Lining Stem Cells
-
Gainesville, FloridaUniversity of Florida
Jan 31, 2023
DM and Pre-DM Risk Prediction Model
Active, not recruiting
- Diabetes Mellitus
- Pre Diabetes
- OGTT and HbA1c
-
Hong Kong, Hong KongDepartment of Family Medicine & Primary Care, LKS Faculty of Med
May 17, 2022
Type 1 Diabetes, Type 2 Diabetes Trial in Tunbridge Wells (Four Week Self-Compassion Course)
Not yet recruiting
- Type 1 Diabetes
- Type 2 Diabetes
- Four Week Self-Compassion Course
-
Tunbridge Wells, United KingdomSalomons Institute for Applied Psychology, Canterbury Christ Chu
Mar 1, 2023
Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))
Recruiting
- Advanced Breast Cancer
- +2 more
- Trastuzumab Emtansine (T-DM1)
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Nov 5, 2023
Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)
Completed
- Healthy Subjects
- +2 more
- HEC88473 injection
- Placebo
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jul 14, 2023
Type 2 Diabetes Trial (Intensive experiential training in T2DM management, Regular training in T2DM management)
Not yet recruiting
- Type 2 Diabetes
- Intensive experiential training in T2DM management
- Regular training in T2DM management
- (no location specified)
Feb 6, 2023
Devices (Mitra® and HemaPEN®)
Not yet recruiting
- Phenylketonuria
- Metabolic Diseases
- DM-DIV MITRA®
- (no location specified)
Jun 8, 2023
Hip Osteoarthritis Trial in Winnipeg, London (Pinnacle Gription Acetabular Cup, Pinnacle Dual Mobility)
Active, not recruiting
- Hip Osteoarthritis
- Pinnacle Gription Acetabular Cup
- Pinnacle Dual Mobility
-
Winnipeg, Manitoba, Canada
- +1 more
Jun 26, 2023
Diabetes, Type 2 Trial in Worcester (Diabetes BOOST, Usual Care)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Diabetes BOOST
- Usual Care
-
Worcester, MassachusettsUniversity of Massachusetts Medical School
Jan 3, 2023
Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)
Not yet recruiting
- Metastatic Solid Tumor
- Brain Metastases
- Trastuzumab emtansine
- Tucatinib
-
Houston, TexasM D Anderson Cancer Center
Dec 30, 2022
Breast Cancer Trial (Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F
Not yet recruiting
- Breast Cancer
- Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502)
- Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
- (no location specified)
Feb 22, 2023